Expired Tender Czech Republic ICB TOT Ref. 92725276

Delivery of Medicinal Products with the Active Tender - 92725276

Tender notice from Czech Republic, published on 25 Nov 2023.

Executive Summary

The HOSPITAL IN FRYDEK-MISTEK, CONTRIBUTION ORGANIZATION has issued a Tender notice for the procurement of a Delivery of Medicinal Products with the Active Ingredient Faricimab and Brolucizumab in the Czech Republic. This Tender notice was published on 25 Nov 2023 and is scheduled to close on 05 Jan 2024, with an estimated Tender value of CZK 12592256. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 92725276, while the tender notice number is 715293-2023 and Register on the platform.

Key facts

Summary
Delivery of Medicinal Products with the Active Ingredient Faricimab and Brolucizumab
TOT Ref. No.
92725276
Document Ref. No.
715293-2023
Country
Czech Republic
Notice type
Tender
Competition
ICB
Publication date
25 Nov 2023
Bid deadline
05 Jan 2024
EMD
Refer Document
Tender value
CZK 12592256
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

The ordering party requests continuous supplies of the medicinal product with the active ingredients Faricimab and Brolucizumab according to the ordering party's current needs and its individual orders for the Hospital in Frydek-Mistek, p.o.
Doc Title: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Contract Type: Supplies
Document Type: Contract notice

Reference Number: P/015/SKL/23

Contract Type: Supplies

Estimated Value: 12592256 - CZK

33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

Authority Type: Regional or local authority

Type of Procedure: Open procedure

Regulation: European Union

Bid Type: Submission for all lots

Doc Title: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

Dispatch Date: 2023-11-21

Publish Date: 2023-11-24

Submission Date: 2024-01-05

Documents

Tender Notice
Login to view

Similar tenders

Czech Republic Public Procurement Intelligence

Frequently asked questions

The bid deadline for Delivery of Medicinal Products with the Active Ingredient Faricimab and Brolucizumab was 05 Jan 2024. Bidding is closed.

This tender has been issued by HOSPITAL IN FRYDEK-MISTEK, CONTRIBUTION ORGANIZATION in Czech Republic.

The estimated tender value is CZK 12592256. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 92725276. The purchaser document reference is 715293-2023.

See the Similar Tenders section on this page or browse other tenders from Czech Republic.

This tender falls under Materials and Products, Technology and Equipment in Czech Republic. Suppliers in these sectors can track similar Czech Republic tenders using CPV-based alerts.